Search Results

There are 6769 results for: content related to: Therapy of Chronic Lymphocytic Leukemia: Front-Line and Salvage

  1. Bendamustine: A New Treatment Option for Chronic Lymphocytic Leukemia

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 29, Issue 11, November 2009, Pages: 1375–1384, Dr. Ashley E. Glode and Dr. Anthony Jarkowski III

    Article first published online : 6 JAN 2012, DOI: 10.1592/phco.29.11.1375

  2. Bendamustine for patients with indolent B cell lymphoid malignancies including chronic lymphocytic leukaemia

    Intervention Review

    The Cochrane Library

    Liat Vidal, Anat Gafter-Gvili, Ronit Gurion, Pia Raanani, Martin Dreyling and Ofer Shpilberg

    Published Online : 12 SEP 2012, DOI: 10.1002/14651858.CD009045.pub2

  3. You have free access to this content
    Bendamustine with or without rituximab in the treatment of relapsed chronic lymphocytic leukaemia: an Italian retrospective study

    British Journal of Haematology

    Volume 153, Issue 3, May 2011, Pages: 351–357, Emilio Iannitto, Fortunato Morabito, Salvatrice Mancuso, Massimo Gentile, Antonella Montanini, Accursio Augello, Velia Bongarzoni, Alfonso D’Arco, Nicola Di Renzo, Rita Fazzi, Giovanni Franco, Roberto Marasca, Antonino Mulè, Maurizio Musso, Pellegrino Musto, Elsa Pennese, Andrea Piccin, Delia Rota-Scalabrini, Giuseppe Visani and Luigi Rigacci

    Article first published online : 4 MAR 2011, DOI: 10.1111/j.1365-2141.2011.08597.x

  4. You have free access to this content
    Bendamustine compared with chlorambucil in previously untreated patients with chronic lymphocytic leukaemia: updated results of a randomized phase III trial

    British Journal of Haematology

    Volume 159, Issue 1, October 2012, Pages: 67–77, Wolfgang U. Knauf, Toshko Lissitchkov, Ali Aldaoud, Anna M. Liberati, Javier Loscertales, Raoul Herbrecht, Gunnar Juliusson, Gerhard Postner, Liana Gercheva, Stefan Goranov, Martin Becker, Hans-Joerg Fricke, Francoise Huguet, Ilaria Del Giudice, Peter Klein, Karlheinz Merkle and Marco Montillo

    Article first published online : 4 AUG 2012, DOI: 10.1111/bjh.12000

  5. You have free access to this content
    Navitoclax (ABT-263) and bendamustine ± rituximab induce enhanced killing of non-Hodgkin's lymphoma tumours in vivo

    British Journal of Pharmacology

    Volume 167, Issue 4, October 2012, Pages: 881–891, S Ackler, MJ Mitten, J Chen, J Clarin, K Foster, S Jin, DC Phillips, S Schlessinger, B Wang, JD Leverson and ER Boghaert

    Article first published online : 25 SEP 2012, DOI: 10.1111/j.1476-5381.2012.02048.x

  6. You have free access to this content
    Bendamustine

    Cancer

    Volume 115, Issue 3, 1 February 2009, Pages: 473–479, Matt Kalaycio

    Article first published online : 31 DEC 2008, DOI: 10.1002/cncr.24057

  7. You have free access to this content
    Bendamustine in chronic lymphocytic leukemia: Outcome according to different clinical and biological prognostic factors in the everyday clinical practice

    American Journal of Hematology

    Volume 88, Issue 11, November 2013, Pages: 955–960, Francesco Zaja, Michael Mian, Stefano Volpetti, Carlo Visco, Cinzia Sissa, Ilaria Nichele, Monica Castelli, Achille Ambrosetti, Simona Puglisi, Renato Fanin, Sergio Cortelazzo, Giovanni Pizzolo, Livio Trentin, Francesco Rodeghiero, Rossella Paolini, Paolo Vivaldi, Rosaria Sancetta, Miriam Isola and Gianpietro Semenzato

    Article first published online : 9 SEP 2013, DOI: 10.1002/ajh.23546

  8. A new hope: novel therapeutic approaches to treatment of chronic lymphocytic leukaemia with defects in TP53

    British Journal of Haematology

    Volume 167, Issue 2, October 2014, Pages: 149–161, Polina Shindiapina, Jennifer R. Brown and Alexey V. Danilov

    Article first published online : 20 JUL 2014, DOI: 10.1111/bjh.13042

  9. You have free access to this content
    Bendamustine is effective in T-Cell prolymphocytic leukaemia

    British Journal of Haematology

    Charles Herbaux, Philippe Genet, Krimo Bouabdallah, Jean-Michel Pignon, Houria Debarri, Stéphanie Guidez, Sarah Betrian, Xavier Leleu, Thierry Facon, Franck Morschhauser, Gandhi Damaj, Bruno Cazin and Loïc Ysebaert

    Article first published online : 15 OCT 2014, DOI: 10.1111/bjh.13175

  10. Bendamustine for patients with indolent B cell lymphoid malignancies including chronic lymphocytic leukaemia

    International Journal of Evidence-Based Healthcare

    Volume 11, Issue 2, June 2013, Pages: 145–146, Sharmila Binte Shamshad Ali

    Article first published online : 10 JUN 2013, DOI: 10.1111/1744-1609.12018

  11. You have full text access to this Open Access content
    Phase I and pharmacokinetic study of bendamustine hydrochloride in relapsed or refractory indolent B-cell non-Hodgkin lymphoma and mantle cell lymphoma

    Cancer Science

    Volume 101, Issue 9, September 2010, Pages: 2054–2058, Michinori Ogura, Toshiki Uchida, Masafumi Taniwaki, Kiyoshi Ando, Takashi Watanabe, Masanobu Kasai, Yosuke Matsumoto, Daisuke Shimizu, Yoshiaki Ogawa, Ken Ohmachi, Hiroki Yokoyama, Kensei Tobinai and the Japanese Bendamustine Lymphoma Study Group

    Article first published online : 27 MAY 2010, DOI: 10.1111/j.1349-7006.2010.01633.x

  12. Pharmacokinetic profile and first preliminary clinical evaluation of bendamustine in Taiwanese patients with heavily pretreated indolent B-cell non-Hodgkin lymphoma and mantle cell lymphoma

    Hematological Oncology

    Liang-Tsai Hsiao, Hwei-Fang Tien, Ching-Yuan Kuo, Jin-Hou Wu, Hsin-An Hou, Ming-Chung Wang, Chun-Yu Liu, Po-Min Chen and Tzeon-Jye Chiou

    Article first published online : 11 AUG 2014, DOI: 10.1002/hon.2161

  13. You have full text access to this OnlineOpen article
    Routine treatment of patients with chronic lymphocytic leukaemia by office-based haematologists in Germany—data from the Prospective Tumour Registry Lymphatic Neoplasms

    Hematological Oncology

    Wolfgang Knauf, Wolfgang Abenhardt, Steffen Dörfel, Dirk Meyer, Renate Grugel, Michaela Münz, Holger Hartmann and Norbert Marschner

    Article first published online : 15 APR 2014, DOI: 10.1002/hon.2139

  14. You have free access to this content
    Bendamustine is effective therapy in patients with rituximab-refractory, indolent B-cell non-Hodgkin lymphoma

    Cancer

    Volume 116, Issue 1, 1 January 2010, Pages: 106–114, Brad S. Kahl, Nancy L. Bartlett, John P. Leonard, Ling Chen, Kristen Ganjoo, Michael E. Williams, Myron S. Czuczman, K. Sue Robinson, Robin Joyce, Richard H. van der Jagt and Bruce D. Cheson

    Article first published online : 4 NOV 2009, DOI: 10.1002/cncr.24714

  15. You have full text access to this Open Access content
    Feasibility and pharmacokinetic study of bendamustine hydrochloride in combination with rituximab in relapsed or refractory aggressive B cell non-Hodgkin’s lymphoma

    Cancer Science

    Volume 102, Issue 9, September 2011, Pages: 1687–1692, Michinori Ogura, Kiyoshi Ando, Masafumi Taniwaki, Takashi Watanabe, Toshiki Uchida, Ken Ohmachi, Yosuke Matsumoto, Kensei Tobinai and for the Japanese Bendamustine Lymphoma Study Group

    Article first published online : 7 JUL 2011, DOI: 10.1111/j.1349-7006.2011.01994.x

  16. Bendamustine and rituximab combination in the management of chronic lymphocytic leukemia-associated autoimmune hemolytic anemia: A multicentric retrospective study of the French CLL intergroup (GCFLLC/MW and GOELAMS)

    American Journal of Hematology

    Volume 90, Issue 3, March 2015, Pages: 204–207, Anne Quinquenel, Christophe Willekens, Jehan Dupuis, Bruno Royer, Loic Ysebaert, S. De Guibert, Anne-Sophie Michallet, Pierre Feugier, Romain Guieze, Vincent Levy and Alain Delmer

    Article first published online : 16 JAN 2015, DOI: 10.1002/ajh.23909

  17. You have free access to this content
    Phase I/II trial assessing bendamustine plus bortezomib combination therapy for the treatment of patients with relapsed or refractory multiple myeloma

    British Journal of Haematology

    Volume 160, Issue 3, February 2013, Pages: 321–330, James R. Berenson, Ori Yellin, Alberto Bessudo, Ralph V. Boccia, Stephen J. Noga, Donald S. Gravenor, Dipti Patel-Donnelly, Robert S. Siegel, Tarun Kewalramani, Edward J. Gorak, Youram Nassir, Regina A. Swift and Debra Mayo

    Article first published online : 15 NOV 2012, DOI: 10.1111/bjh.12129

  18. Successful administration of rituximab–bendamustine regimen in the relapse of Hodgkin lymphoma after autologous hemopoietic stem cell transplantation

    Hematological Oncology

    Volume 30, Issue 2, June 2012, Pages: 98–100, Ferenc Magyari, Zsofia Simon, Sandor Barna, Miklos Udvardy, László Váróczy and Árpád Illés

    Article first published online : 28 OCT 2011, DOI: 10.1002/hon.1004

  19. You have free access to this content
    Efficacy and safety of bendamustine for the treatment of patients with recurring Hodgkin lymphoma

    British Journal of Haematology

    Volume 160, Issue 2, January 2013, Pages: 207–215, Gaetano Corazzelli, Francesco Angrilli, Alfonso D'Arco, Felicetto Ferrara, Pellegrino Musto, Attilio Guarini, Maria Christina Cox, Caterina Stelitano, Sergio Storti, Emilio Iannitto, Simona Falorio, Catello Califano, Alfonso Amore, Manuela Arcamone, Rosaria De Filippi and Antonio Pinto

    Article first published online : 20 NOV 2012, DOI: 10.1111/bjh.12120

  20. You have free access to this content
    United Kingdom Myeloma Forum (UKMF) position statement on the use of bendamustine in myeloma

    International Journal of Laboratory Hematology

    Volume 36, Issue 1, February 2014, Pages: 20–28, G. Pratt, S. Bowcock, M. Lai, S. Bell, J. Bird, S. D'Sa, J. Cavenagh, G. Cook, G. Morgan, R. Owen, J.A. Snowden, K. Yong and F. Davies, The United Kingdom Myeloma Forum

    Article first published online : 25 APR 2013, DOI: 10.1111/ijlh.12097